Bioequivalence Study of Daclatasvir From Daktavira 60 mg Film Coated Tablets ( European Egyptian Pharmaceutical Industries, Egypt) Versus Daklinza 60 mg Tablets (Bristol-Myers Squibb Pharma, UK)

Clinical Trial ID NCT02675127

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02675127

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability. J Pharmacokinet Biopharm 1987 8.01
2 On sample size calculation in bioequivalence trials. J Pharmacokinet Pharmacodyn 2001 2.40
3 Sample size determination for bioequivalence assessment by means of confidence intervals. Int J Clin Pharmacol Ther Toxicol 1991 2.07
Next 100